The Acyclic Retinoid Peretinoin Inhibits Hepatitis C Virus Replication and Infectious Virus Release in Vitro

Clinical studies suggest that the oral acyclic retinoid Peretinoin may reduce the recurrence of hepatocellular carcinoma (HCC) following surgical ablation of primary tumours. Since hepatitis C virus (HCV) infection is a major cause of HCC, we assessed whether Peretinoin and other retinoids have any...

Descripción completa

Detalles Bibliográficos
Autores principales: Shimakami, Tetsuro, Honda, Masao, Shirasaki, Takayoshi, Takabatake, Riuta, Liu, Fanwei, Murai, Kazuhisa, Shiomoto, Takayuki, Funaki, Masaya, Yamane, Daisuke, Murakami, Seishi, Lemon, Stanley M., Kaneko, Shuichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2014
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3986704/
https://www.ncbi.nlm.nih.gov/pubmed/24732793
http://dx.doi.org/10.1038/srep04688

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3986704/
https://www.ncbi.nlm.nih.gov/pubmed/24732793
http://dx.doi.org/10.1038/srep04688

Ejemplares similares